1.78 Keros Therapeutics Reports Widening Losses in Q1 2024, Despite Progress in Clinical Trials

News > Business


<< back

Keros Therapeutics Reports Widening Losses in Q1 2024, Despite Progress in Clinical Trials
Date: 2024-05-10 [news.yahoo.com]

READ THE FULL NEWS >>
×